144 related articles for article (PubMed ID: 11215332)
1. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats.
Kato M; Okano K; Sakamoto Y; Miura K; Uchimura T; Saito K
Arzneimittelforschung; 2001 Jan; 51(1):91-5. PubMed ID: 11215332
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
[TBL] [Abstract][Full Text] [Related]
3. Immunological response to repeated administration of recombinant human erythropoietin in rats: biphasic effect on its pharmacokinetics.
Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
Drug Metab Dispos; 1997 Sep; 25(9):1039-44. PubMed ID: 9311618
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R
Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.
Kinoshita H; Ohishi N; Tokura S; Okazaki A
Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Yoon WH; Park SJ; Kim IC; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
[TBL] [Abstract][Full Text] [Related]
7. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats.
Kato M; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 1997 Nov; 283(2):520-7. PubMed ID: 9353365
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
Ait-Oudhia S; Scherrmann JM; Krzyzanski W
J Pharmacol Exp Ther; 2010 Sep; 334(3):897-910. PubMed ID: 20501635
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin response and route of administration.
Taylor JE; Belch JJ; Fleming LW; Mactier RA; Henderson IS; Stewart WK
Clin Nephrol; 1994 May; 41(5):297-302. PubMed ID: 8050210
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
Köhler M; Mörsdorf S; Jung F; Braun B; Waldhausen P; Pindur G; Weber U; Bosslet R; Bambauer R; Jutzler GA
Beitr Infusionsther; 1990; 26():89-95. PubMed ID: 1703909
[TBL] [Abstract][Full Text] [Related]
13. Biological characterization of recombinant human erythropoietin.
Krumwieh D; Arnold I; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
Salmonson T
Scand J Urol Nephrol Suppl; 1990; 129():1-66. PubMed ID: 2255869
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of recombinant human erythropoietin (r-HuEPO).
Flaharty KK
Pharmacotherapy; 1990; 10(2 ( Pt 2)):9S-14S. PubMed ID: 2345710
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of erythropoietin in genetically anemic mice.
Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298
[TBL] [Abstract][Full Text] [Related]
17. Enteral administration of recombinant erythropoietin to preterm infants.
Britton JR; Christensen RD
J Perinatol; 1995; 15(4):281-3. PubMed ID: 8558334
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes.
Varlet-Marie E; Gaudard A; Audran M; Gomeni R; Bressolle F
Int J Sports Med; 2003 May; 24(4):252-7. PubMed ID: 12784166
[TBL] [Abstract][Full Text] [Related]
19. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
Janicka L; Ksiazek A; Baranowicz I; Mierzicki P
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():67-77. PubMed ID: 8192534
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients.
Brockmöller J; Köchling J; Weber W; Looby M; Roots I; Neumayer HH
Br J Clin Pharmacol; 1992 Dec; 34(6):499-508. PubMed ID: 1493082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
